Tearsheet
Investment Highlights Market Valuation Price Chart Business Description Interactive Breakdown Latest Trefis Analyses Better Bets vs. CL Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Colgate-Palmolive (CL)

Market Price (9/18/2025): $82.25 | Market Cap: $66.6 Bil
Sector: Consumer Staples | Industry: Household Products

Colgate-Palmolive (CL)

Market Price (9/18/2025): $82.25
Market Cap: $66.6 Bil
Sector: Consumer Staples
Industry: Household Products

Investment Highlights

0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.1%, Dividend Yield is 2.7%, FCF Yield is 5.1%		 Weak multi-year price returns
2Y Excs Rtn is -30%, 3Y Excs Rtn is -47%		 
1 Attractive operating margins
Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 22%		  
2 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 20%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 17%, CFO LTM is 3.9 Bil, FCF LTM is 3.4 Bil		  
3 Low stock price volatility
Vol 12M is 21%		  
0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.1%, Dividend Yield is 2.7%, FCF Yield is 5.1%
1 Attractive operating margins
Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 22%
2 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 20%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 17%, CFO LTM is 3.9 Bil, FCF LTM is 3.4 Bil
3 Low stock price volatility
Vol 12M is 21%
4 Weak multi-year price returns
2Y Excs Rtn is -30%, 3Y Excs Rtn is -47%

Market Valuation

 9/18/252024202320222021
Share Price CYE$82.25$89.36$76.66$73.87$78.11
Market Cap CYE ($ Bil)66.672.963.161.565.8
Total Debt ($ Bil)8.88.59.19.37.8
Total Cash ($ Bil)1.21.11.00.80.8
Enterprise Value ($ Bil)74.281.472.270.873.6
Valuation Ratios     
P/S TTM3.33.73.43.74.1
P/EBIT TTM15.817.517.923.322.5
P/E TTM22.925.828.736.933.3
Sector Ratios     
P/S TTM (Sector)0.90.90.90.91.6
P/EBIT TTM (Sector)8.48.910.09.411.6
P/E TTM (Sector)12.612.114.011.616.2
 9/18/2520242023
Share Price CYE$82.25$89.36$76.66
Market Cap CYE ($ Bil)66.672.963.1
Total Debt ($ Bil)8.88.59.1
Total Cash ($ Bil)1.21.11.0
Enterprise Value ($ Bil)74.281.472.2
Valuation Ratios   
P/S TTM3.33.73.4
P/EBIT TTM15.817.517.9
P/E TTM22.925.828.7
Sector Ratios   
P/S TTM (Sector)0.90.90.9
P/EBIT TTM (Sector)8.48.910.0
P/E TTM (Sector)12.612.114.0

Market Cap Chart

Business Description

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. Show more

Price Returns Compared

Expand for Detailed View

 202020212022202320242025Total [1]
Returns
CL Return27%2%-5%4%17%-8%38%
Peers Return18%6%-5%-2%12%-1%29%
S&P 500 Return16%27%-19%24%23%12%104%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: JNJ, PG, KMB, CLX, CL. See CL Returns vs. Peers.
[3] 2025 data is for the year up to 9/17/2025 (YTD)

Interactive Breakdown

Colgate-Palmolive Interactive Breakdown Analysis

Better Bets than Colgate-Palmolive (CL)

 CLBetter Performance than CL
MetricValueIndustry (Household Products)
Rev Chg LTM0.1%UL (11.1%), CHD (1.1%), CLX (0.2%), IPAR (7.0%), WDFC (6.5%)
Rev Chg 3Y Avg4.2%CHD (4.6%), IPAR (14.9%), WDFC (6.8%), HNST (7.9%), SLSN (26.0%)
Op Mgn LTM21.7%EWCZ (22.1%), UG (25.9%)
CFO/Rev LTM19.6%EWCZ (27.9%)
FCF/Rev LTM16.9%EWCZ (27.1%)
Total Yield7.1%KMB (9.8%), CLX (7.2%), IPAR (7.8%), ENR (16.1%), SPB (7.3%)
 CLBetter Performance than CL
MetricValueAll Other Sectors
Rev Chg LTM0.1%NVDA (71.6%), MSFT (14.9%), AAPL (6.0%), GOOGL (13.1%), AMZN (10.9%)
Rev Chg 3Y Avg4.2%NVDA (92.0%), MSFT (12.5%), GOOGL (10.2%), AMZN (11.3%), META (13.0%)
Op Mgn LTM21.7%NVDA (58.1%), MSFT (45.6%), AAPL (31.9%), GOOGL (32.7%), META (42.9%)
CFO/Rev LTM19.6%NVDA (46.6%), MSFT (48.3%), AAPL (26.6%), GOOGL (36.0%), META (56.4%)
FCF/Rev LTM16.9%NVDA (43.6%), MSFT (25.4%), AAPL (23.5%), GOOGL (18.0%), META (30.7%)
Total Yield7.1%XOM (9.7%), JNJ (8.1%), BABA (37.9%), UNH (9.4%), CVX (9.2%)

Latest Trefis Analyses

TitleTopicDate
0DASHBOARDS  
1Colgate-Palmolive Earnings Notes  
2Colgate-Palmolive vs Johnson & Johnson: Which Is A Better Investment?Counter-Intuitive Comparisons 
3Colgate-Palmolive vs Cal-Maine Foods: Which Is A Better Investment?Counter-Intuitive Comparisons 
4Better Bet Than CL Stock: Pay Less Than Colgate-Palmolive To Get More From UNH, DIS   
5Better Bet Than CL Stock: Pay Less Than Colgate-Palmolive To Get More From USFD, PPC   
6Day 10 of Loss Streak for Colgate-Palmolive Stock with -6.6% Return (vs. -3% YTD) [7/21/2025]Notification 
7Day 9 of Loss Streak for Colgate-Palmolive Stock with -6.4% Return (vs. -2.8% YTD) [7/18/2025]Notification 
8Day 8 of Loss Streak for Colgate-Palmolive Stock with -7.1% Return (vs. -3.5% YTD) [7/17/2025]Notification 
9Day 7 of Loss Streak for Colgate-Palmolive Stock with -6.1% Return (vs. -2.5% YTD) [7/16/2025]Notification 
10Colgate-Palmolive Total Shareholder Return (TSR): 19.2% in 2024 and 7.1% 3-yr compounded annual returns (above peer average)  
11ARTICLES  
12CL Stock Down -6.6% after 10-Day Loss Streak July 22nd, 2025
13CL Stock Down -6.4% after 9-Day Loss Streak July 19th, 2025
14CL Stock Down -7.1% after 8-Day Loss Streak July 18th, 2025
15CL Stock Down -6.1% after 7-Day Loss Streak July 17th, 2025
16Better Bet Than Procter & Gamble Stock: Pay Less To Get More From Industry Peer July 14th, 2025
Title
0DASHBOARDS
1CL Stock Down -6.6% after 10-Day Loss Streak
2CL Stock Down -6.4% after 9-Day Loss Streak
3CL Stock Down -7.1% after 8-Day Loss Streak
4CL Stock Down -6.1% after 7-Day Loss Streak
5Better Bet Than Procter & Gamble Stock: Pay Less To Get More From Industry Peer
6ARTICLES
7Colgate-Palmolive Earnings Notes
8Colgate-Palmolive vs Johnson & Johnson: Which Is A Better Investment?
9Colgate-Palmolive vs Cal-Maine Foods: Which Is A Better Investment?
10Better Bet Than CL Stock: Pay Less Than Colgate-Palmolive To Get More From UNH, DIS 
11Better Bet Than CL Stock: Pay Less Than Colgate-Palmolive To Get More From USFD, PPC 
12Day 10 of Loss Streak for Colgate-Palmolive Stock with -6.6% Return (vs. -3% YTD) [7/21/2025]
13Day 9 of Loss Streak for Colgate-Palmolive Stock with -6.4% Return (vs. -2.8% YTD) [7/18/2025]
14Day 8 of Loss Streak for Colgate-Palmolive Stock with -7.1% Return (vs. -3.5% YTD) [7/17/2025]
15Day 7 of Loss Streak for Colgate-Palmolive Stock with -6.1% Return (vs. -2.5% YTD) [7/16/2025]
16Colgate-Palmolive Total Shareholder Return (TSR): 19.2% in 2024 and 7.1% 3-yr compounded annual returns (above peer average)

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1ECDAECD Automotive Design3347.2%307.9%
2BDSXBiodesix1090.6%-79.7%
3CLSDClearside Biomedical987.7%-74.7%
4ATHAAthira Pharma892.1%544.3%
5SDOTSadot690.6%-79.9%
6ATCHAtlasClear684.9%-83.1%
7HSDTHelius Medical Technologies232.1%-95.5%
8CHEKCheck-Cap222.2%134.4%
9APLMApollomics197.8%89.1%
10SPRCSciSparc147.0%1141.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1CURXCuranex Pharmaceuticals-80.5%148.4%
2ATYRaTyr Pharma-80.4%-71.7%
3NAKAKindly MD-70.2% 
4BNGOBionano Genomics-64.0%-89.8%
5XAGELongevity Health-57.6%-86.1%
6FAASDigiAsia-55.4%-88.0%
7ASSTStrive-54.5%650.3%
8VCIGVCI Global-51.0%-98.9%
9REXREX American Resources-50.7%44.3%
10RBNERobin Energy-42.6% 

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1PMIPicard Medical11931.7%11931.7%
2GIBOGIBO10714.0% 
3LNZALanzaTech Global8455.2%-86.3%
4GTIGraphjet Technology3998.4%-93.1%
5GWAVGreenwave Technology Solutions3582.8%-91.4%
6QMMMQMMM3409.6%8153.1%
7ECDAECD Automotive Design2715.2%307.9%
8OESXOrion Energy Systems1373.7%14.2%
9OPOceanPal1266.5%-95.6%
10BCTXBriaCell Therapeutics1032.4%-89.8%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1CJETChijet Motor-94.5%-96.0%
2STFSStar Fashion Culture-92.3%-97.9%
3ELPWElong Power-91.1%-76.9%
4NXTTNext Technology-90.1%-95.4%
5EPIXESSA Pharma-89.4%-8.9%
6NAKAKindly MD-88.1% 
7BINIBollinger Innovations-87.6%-100.0%
8JEM707 Cayman-87.4%-98.2%
9YAASYouxin Technology-83.3%-98.4%
10NEONNeonode-82.5%-51.0%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1ECDAECD Automotive Design3347.2%307.9%
2BDSXBiodesix1090.6%-79.7%
3CLSDClearside Biomedical987.7%-74.7%
4ATHAAthira Pharma892.1%544.3%
5SDOTSadot690.6%-79.9%
6ATCHAtlasClear684.9%-83.1%
7HSDTHelius Medical Technologies232.1%-95.5%
8CHEKCheck-Cap222.2%134.4%
9APLMApollomics197.8%89.1%
10SPRCSciSparc147.0%1141.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1CURXCuranex Pharmaceuticals-80.5%148.4%
2ATYRaTyr Pharma-80.4%-71.7%
3NAKAKindly MD-70.2% 
4BNGOBionano Genomics-64.0%-89.8%
5XAGELongevity Health-57.6%-86.1%
6FAASDigiAsia-55.4%-88.0%
7ASSTStrive-54.5%650.3%
8VCIGVCI Global-51.0%-98.9%
9REXREX American Resources-50.7%44.3%
10RBNERobin Energy-42.6% 

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Colgate-Palmolive

Financials

CLJNJPGKMBCLXMedian
NameColgate-.Johnson .Procter .Kimberly.Clorox  
Mkt Price82.22177.20160.33125.59125.40125.59
Mkt Cap66.6426.4376.041.715.466.6
Rev LTM19,99990,62784,28418,8837,10419,999
Op Inc LTM4,34622,22820,4503,1601,1834,346
FCF LTM3,37016,39714,0442,1027613,370
FCF 3Y Avg3,02816,92614,7852,4567253,028
CFO LTM3,92023,02817,8172,8729813,920
CFO 3Y Avg3,65922,24818,1703,2219453,659

Growth & Margins

CLJNJPGKMBCLXMedian
NameColgate-.Johnson .Procter .Kimberly.Clorox  
Rev Chg LTM0.1%4.7%0.3%-3.1%0.2%0.2%
Rev Chg 3Y Avg4.2%4.0%1.7%-2.1%0.0%1.7%
Rev Chg Q1.0%5.8%1.7%-1.6%4.5%1.7%
QoQ Delta Rev Chg LTM0.3%1.5%0.4%-0.4%1.2%0.4%
Op Mgn LTM21.7%24.5%24.3%16.7%16.7%21.7%
Op Mgn 3Y Avg21.2%26.3%23.3%15.2%12.7%21.2%
QoQ Delta Op Mgn LTM-0.1%-0.2%0.5%0.3%1.4%0.3%
CFO/Rev LTM19.6%25.4%21.1%15.2%13.8%19.6%
CFO/Rev 3Y Avg18.7%25.7%21.8%16.5%13.1%18.7%
FCF/Rev LTM16.9%18.1%16.7%11.1%10.7%16.7%
FCF/Rev 3Y Avg15.4%19.6%17.7%12.5%10.0%15.4%

Valuation

CLJNJPGKMBCLXMedian
NameColgate-.Johnson .Procter .Kimberly.Clorox  
Mkt Cap66.6426.4376.041.715.466.6
P/S3.34.74.52.22.23.3
P/EBIT15.815.117.813.713.215.1
P/E22.918.823.517.219.119.1
P/CFO17.018.521.114.515.717.0
Total Yield7.1%8.1%4.2%9.8%7.2%7.2%
Dividend Yield2.7%2.8%0.0%3.9%1.9%2.7%
FCF Yield 3Y Avg4.2%4.5%3.9%5.4%4.2%4.2%
D/E0.10.10.10.20.20.1
Net D/E0.10.10.10.20.20.1

Returns

CLJNJPGKMBCLXMedian
NameColgate-.Johnson .Procter .Kimberly.Clorox  
1M Rtn-2.4%1.3%3.0%-3.4%5.0%1.3%
3M Rtn-6.2%18.4%2.2%-0.9%4.8%2.2%
6M Rtn-8.0%10.5%-3.6%-8.3%-12.0%-8.0%
12M Rtn-19.6%9.5%-6.5%-8.0%-21.2%-8.0%
3Y Rtn16.6%15.8%25.1%14.9%-2.2%15.8%
1M Excs Rtn-4.8%-1.1%0.6%-5.8%2.6%-1.1%
3M Excs Rtn-17.0%6.8%-8.5%-12.0%-6.6%-8.5%
6M Excs Rtn-24.6%-7.9%-20.7%-25.8%-29.4%-24.6%
12M Excs Rtn-37.8%-6.8%-22.9%-26.5%-39.3%-26.5%
3Y Excs Rtn-47.3%-43.4%-38.0%-50.1%-66.9%-47.3%

Comparison Analyses

Title
0Colgate-Palmolive vs. Procter & Gamble: With Return Forecast Of 8.7%, Colgate-Palmolive Is A Better Bet
1MNST Looks Stronger Than CL With 23% Return Potential
2Why MAR With 26% Upside May Beat CL?
3KMB or CL - With 12% Return Forecast, CL Probably Deserves Your Money
4Colgate Palmolive vs. Johnson & Johnson: With Return Forecast Of 7.4%, Colgate Palmolive Is A Better Bet
5Colgate Palmolive vs. Clorox: With Return Forecast Of 7.7%, Colgate Palmolive Is A Better Bet
6Colgate Palmolive vs. Mastercard: With Return Forecast Of 33%, Mastercard Is A Better Bet
7Colgate Palmolive vs. McDonald's: With Return Forecast Of 6.1%, Colgate Palmolive Is A Better Bet
8Colgate Palmolive vs. Texas Instruments: Neither Seems Like A Good Bet
9Colgate Palmolive vs. Charter Communications: With Return Forecast Of 33%, Charter Communications Is A Better Bet

Financials

$ Mil | FY: 12/312025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q22023Q12022Q42022Q3
Period End6/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/20236/30/20233/31/202312/31/20229/30/2022
Filing Date8/1/20254/25/20252/13/202510/25/20247/26/20244/26/20242/15/202410/27/20237/28/20234/28/20232/16/202310/28/2022
Key Financials Quarterly            
Total Revenue5,1104,9114,9455,0335,0585,0654,9504,9154,8224,7704,6294,455
Ebitda1,2291,1671,1911,2151,2451,1909171,1731,1191,0372711,081
Operating Income1,0801,0761,1251,0651,0921,0471,1731,029974909926947
Net Income7436907397377316837187085023725618
EPS0.920.850.910.900.890.830.870.860.610.450.010.74
Key Financials TTM            
Total Revenue TTM19,99919,94720,10120,10619,98819,75219,45719,13618,67618,33817,96717,741
Ebitda TTM4,8024,8184,8414,5674,5254,3994,2463,6003,5083,4113,3723,480
Operating Income TTM4,3464,3584,3294,3774,3414,2234,0853,8383,7563,6663,6173,634
Net Income TTM2,9092,8972,8902,8692,8402,6112,3001,5871,4971,5981,7851,928
Growth Rates Quarterly            
Total Revenue Growth1.0%-3.0%-0.1%2.4%4.9%6.2%6.9%10.3%7.5%8.4%5.1%0.9%
EBITDA Growth-1.3%-1.9%29.9%3.6%11.3%14.8%238.4%8.5%9.5%3.9%-28.5%-2.3%
Operating Income Growth-1.1%2.8%-4.1%3.5%12.1%15.2%26.7%8.7%10.2%5.7%-1.8%-2.1%
Net Income Growth1.6%1.0%2.9%4.1%45.6%83.6%14260.0%14.6%-16.7%-33.5%-96.6%-2.5%
Margins Quarterly            
EBITDA Margin24.1%23.8%24.1%24.1%24.6%23.5%18.5%23.9%23.2%21.7%5.9%24.3%
Operating Income Margin21.1%21.9%22.8%21.2%21.6%20.7%23.7%20.9%20.2%19.1%20.0%21.3%
Net Income Margin14.5%14.1%14.9%14.6%14.5%13.5%14.5%14.4%10.4%7.8%0.1%13.9%
Cash & Debt            
Total Cash1,2151,1121,0961,2341,1101,079966951819867775938
Total Debt8,7588,2698,5128,4368,6768,6899,0648,7248,9898,9079,2718,248
Net Debt / (Cash)7,5437,1577,4167,2027,5667,6108,0987,7738,1708,0408,4967,310
Cash Flows Quarterly            
FCF from Operations8846001,2691,1679906811,1361,152722735673969
Cash Flows TTM            
FCF from Operations TTM3,9204,0264,1073,9743,9593,6913,7453,2823,0992,9052,5562,989
Returns to Shareholders Quarterly            
Dividends474406514408473394506396457390485392
Share Repurchases232284455295480509245332371180413104
Return on Invested Capital (ROIC) Quarterly            
ROIC44.0%45.8%47.6%46.6%43.8%41.5%44.6%41.4%28.7%33.4%14.2%39.6%
Return on Invested Capital (ROIC) TTM            
ROIC TTM44.7%47.1%45.0%46.6%43.9%40.5%36.5%33.8%31.1%33.4%31.5%36.8%

Segment Financials

Revenue by Segment

$ Mil20242023202220212020
Oral, Personal and Home Care15,16714,25414,11013,58813,168
Pet Nutrition4,2903,7133,3112,8832,525
Total19,45717,96717,42116,47115,693


Operating Income by Segment
$ Mil20242023202220212020
Oral, Personal and Home Care3,8823,3483,4953,5943,505
Pet Nutrition806850901793703
Corporate-704-1,305-1,064-502-654
Total3,9842,8933,3323,8853,554


Price Behavior

CL Betas & Captures as of 8/31/2025

 1M2M3M6M1Y3Y
Beta0.130.190.450.130.070.22
Up Beta0.340.09-0.000.130.090.24
Down Beta-0.04-0.510.55-0.03-0.080.13
Up Capture10%-5%16%13%1%6%
Bmk +ve Days10223571142415
Stock +ve Days11172657119389
Down Capture10%124%129%40%37%51%
Bmk -ve Days11192754106334
Stock -ve Days10253769130356

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date8292025
Short Interest: Shares Quantity11,610,911
Short Interest: % Change Since 8152025-3.5%
Average Daily Volume4,751,037
Days-to-Cover Short Interest2.44
Basic Shares Quantity810,200,000
Short % of Basic Shares1.4%

Returns Analyses

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
8/1/2025-0.4%1.0%0.3%
4/25/20251.3%-2.2%-0.1%
1/31/2025-4.6%-5.7%2.1%
7/26/20243.0%4.6%8.0%
4/26/20241.9%4.1%4.5%
1/26/20242.0%6.0%6.1%
10/27/2023-1.8%2.4%5.5%
7/28/2023-1.9%-0.7%-4.3%
...
SUMMARY STATS   
# Positive111214
# Negative12119
Median Positive1.9%3.4%4.3%
Median Negative-2.2%-2.2%-2.9%
Max Positive6.2%9.8%11.7%
Max Negative-5.2%-6.3%-7.3%

SEC Filings

Expand for More

Report DateFiling DateFiling
6302025801202510-Q 6/30/2025
3312025425202510-Q 3/31/2025
12312024213202510-K 12/31/2024
93020241025202410-Q 9/30/2024
6302024726202410-Q 6/30/2024
3312024426202410-Q 3/31/2024
12312023215202410-K 12/31/2023
93020231027202310-Q 9/30/2023
6302023728202310-Q 6/30/2023
3312023428202310-Q 3/31/2023
12312022216202310-K 12/31/2022
93020221028202210-Q 9/30/2022
6302022729202210-Q 6/30/2022
3312022429202210-Q 3/31/2022
12312021217202210-K 12/31/2021
93020211029202110-Q 9/30/2021

Insider Activity

Expand for More

 OwnerTitleFiling DateActionPriceSharesTransacted
Value		Value of
Held Shares		Form
0Massey SallyChief Human Resources Officer5192025Sell88.972,250200,1831,119,511Form
1Massey SallyChief Human Resources Officer2272025Sell92.028,000736,1521,362,341Form
2Malcolm GregoryEVP and Controller11272024Sell95.941,054101,121922,943Form
3Wallace Noel R.Chairman, President & CEO11262024Sell95.0033,3333,166,63525,715,455Form
4Tsourapas PanagiotisGrp Pres, Eur& Developing Mkts11052024Sell93.3020,0321,869,0104,587,807Form

External Quote Links


Prefer one of these to Trefis? Tell us why.